サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1609565

前臨床医療機器試験サービスの市場規模、シェア、動向分析レポート：サービス別、地域別、セグメント予測、2025年～2030年

Preclinical Medical Device Testing Services Market Size, Share & Trends Analysis Report By Service (Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing, Package Validation), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
前臨床医療機器試験サービスの市場規模、シェア、動向分析レポート：サービス別、地域別、セグメント予測、2025年～2030年
出版日: 2024年11月05日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

前臨床医療機器試験サービス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の前臨床医療機器試験サービス市場規模は2030年までに65億5,000万米ドルに達し、CAGR 9.20%を記録すると予測されています。

疾病の罹患率の増加は、医療機器の形成のためのさまざまなアプローチをメーカーに提供し、技術的に高度な医療機器に対する需要の増加は、市場成長を促進する主な要因です。

ヘルスケア産業における技術進歩のペースは近年大幅に増加しています。医療機器技術の進歩は、疾病管理におけるシンプルで痛みの少ない治療をサポートしています。さらに、医療機器技術の進歩は、正確で迅速な疾病診断結果に役立つだけでなく、疾病治療のための技術ベースの治療ツールの手頃な価格化にも貢献しています。さらに、数多くの政府機関やヘルスケア機関が医療研究施設を支援しています。この資金援助は、主に世界の医療技術革新の促進を目的としています。したがって、予想される期間における医療機器試験の成長は、技術革新と技術進歩の拡大によって支えられています。

前臨床試験は、新製品を生み出す過程で重要な役割を果たしています。人体試験を開始する前に、この試験の大部分は終了しており、報告書が入手できるはずです。ISO-10993によると、患者に直接接触したり、血液供給に接触したりするクラスII機器については、生体適合性試験結果を510（k）通知書に記載する必要があります。これは、新しい機器のリスクが、先行機器のリスクと「実質的に同等」であることを示すものです。新しい機器の有用性を示すため、電気的安全性を検証するため、あるいは電磁干渉を調べるため、試験には動物実験やベンチ試験も含まれます。

COVID-19は、これらのサービスに対する莫大な需要を生み出しました。上半期の伸びはそれほど大きくなかったが、パンデミックの中、業界が新しい規範をより速いペースで採用したため、下半期にはより大きな伸びとなった。COVIDのために中止された数多くのプロジェクトが再開され、PPEキットの生産とテストが増加しています。パンデミックの間、需要の高い多くの医療機器が、手術に必要な機器から注意をそらしました。COVID-19ワクチン、人工呼吸器、パルスオキシメーターは需要の急増した主な製品です。

前臨床医療機器試験サービス市場レポートハイライト

  • 2024年には、生体適合性試験分野が市場を独占し、45.06%の収益シェアを占めました。この試験は、医療機器開発にとって重要なステップであり、生体適合性の評価は、医療機器メーカーが患者に対する機器の安全性を確保し、規制遵守をサポートするために使用できるデータを提供するのに役立ちます。
  • 化学試験分野は、CAGR 9.63%と最速のCAGRを示すと予想されています。この検査は、医療機器の製造に使用される化学物質を分類、認識、理解するために実施されます。
  • アジア太平洋地域は2024年に世界市場をリードし、医療機器試験サービスのアウトソーシングコストが低いことから、予測期間中に最速のCAGR 9.47%を記録すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 前臨床医療機器試験サービス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 市場分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 前臨床医療機器試験サービス市場：サービス推定・動向分析

  • セグメントダッシュボード
  • 世界の前臨床医療機器試験サービス市場;方法変動分析
  • 2018年から2030年までの世界の前臨床医療機器試験サービスの規模と動向分析（方法別）
  • 生体適合性試験
  • 化学テスト
  • 微生物学および無菌試験
    • バイオバーデン測定
    • 発熱物質およびエンドトキシン検査
    • 無菌試験と検証
    • 抗菌活性試験
    • その他
  • パッケージ検証

第5章 前臨床医療機器試験サービス市場：地域推定・動向分析

  • 地域別市場シェア分析、2024年および2030年
  • 地域市場ダッシュボード
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 企業分類
  • 企業市況分析、2024年
  • 企業プロファイル
    • SGS SA
    • Eurofins Scientific
    • Pace Analytical Services LLC
    • Intertek Group Plc
    • WUXI APPTEC
    • TUV SUD AG
    • Sterigenics International LLC
    • Nelson Labs
    • North American Science Associates, Inc.
    • Charles River Laboratories International, Inc.
図表

List of Tables

  • Table 1. List of Tables
  • Table 2. List of Secondary Sources
  • Table 3. List of Abbreviations
  • Table 4. Global Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 5. Global Preclinical Medical Device Testing Services Market, by Region, 2018 - 2030 (USD Million)
  • Table 6. North America Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 7. North America Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 8. U.S. Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 9. Canada Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 10. Mexico Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 11. Europe Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 12. Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 13. UK Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 14. Germany Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 15. France Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 16. Italy Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 17. Spain Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 18. Denmark Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 19. Sweden Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 20. Norway Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 21. Asia Pacific Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 22. Asia Pacific Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 23. Japan Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 24. China Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 25. India Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 26. Thailand Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 27. South Korea Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 28. Australia Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 29. Latin America Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 30. Latin America Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 31. Brazil Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 32. Argentina Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 33. Middle East & Africa Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 34. Middle East & Africa Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 35. South Africa Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 36. Saudi Arabia Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 37. UAE Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 38. Kuwait Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for Market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Preclinical Medical Device Testing Services Market revenue, 2018 - 2030 (USD Million)
  • Fig. 10 Preclinical Medical Device Testing Services Market snapshot
  • Fig. 11 Preclinical Medical Device Testing Services Market driver impact
  • Fig. 12 Preclinical Medical Device Testing Services Market restraint impact
  • Fig. 13 Preclinical Medical Device Testing Services Market: Service takeaways (USD Million)
  • Fig. 14 Preclinical Medical Device Testing Services Market: Service movement analysis
  • Fig. 15 Biocompatibility Tests Market, 2018 - 2030 (USD Million)
  • Fig. 16 Chemistry Test Market, 2018 - 2030 (USD Million)
  • Fig. 17 Microbiology & Sterility Testing Market, 2018 - 2030 (USD Million)
  • Fig. 18 Bioburden Determination Market, 2018 - 2030 (USD Million)
  • Fig. 19 Pyrogen & Endotoxin Testing Market, 2018 - 2030 (USD Million)
  • Fig. 20 Sterility Test and Validation Market, 2018 - 2030 (USD Million)
  • Fig. 21 Ethylene Oxide (EO) gas sterilization Market, 2018 - 2030 (USD Million)
  • Fig. 22 Gamma-irradiation Market, 2018 - 2030 (USD Million)
  • Fig. 23 E-beam sterilization Market, 2018 - 2030 (USD Million)
  • Fig. 24 X-ray sterilization Market, 2018 - 2030 (USD Million)
  • Fig. 25 Antimicrobial Activity Testing Market, 2018 - 2030 (USD Million)
  • Fig. 26 Others Market, 2018 - 2030 (USD Million)
  • Fig. 27 Package Validation Market, 2018 - 2030 (USD Million)
  • Fig. 28 Regional Marketplace: Key takeaways
  • Fig. 29 Regional outlook, 2024 & 2030
  • Fig. 30 North America Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 35 UK Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 37 France Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 39 Spain companion animal Health Market, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 42 Norway Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 44 Japan Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 45 China Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 46 India Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East & Africa Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 56 UAE Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 58 Market participant categorization
目次
Product Code: GVR-4-68039-943-4

Preclinical Medical Device Testing Services Market Growth & Trends:

The global preclinical medical device testing services market size is expected to reach USD 6.55 billion by 2030, registering a CAGR of 9.20%, according to a new report by Grand View Research, Inc. The rising incidence of diseases has provided manufacturers with different approaches for the formation of medical devices and increasing demand for technologically advanced medical devices are the main factors driving the market growth.

The pace of technological advancement in the healthcare industry has vastly increased in recent years. Medical device technology advancements support simple, painless treatment during disease management. Additionally, advancements in medical device technology help with accurate and quick disease diagnosis results, as well as the affordability of technology-based therapeutic tools for disease treatment. Furthermore, numerous governmental agencies and healthcare institutions support medical research facilities. This funding is primarily intended to promote global health care innovations. The growth of medical device testing in the anticipated period is therefore supported by expanding innovation and technological advancement.

Preclinical testing plays a crucial role in the process of creating new products. Before beginning human testing, most of this testing has been completed and reports should be available. According to ISO-10993, biocompatibility testing results are needed to be included in 510(k) notifications for Class II equipment that has immediate patient contact or contact with the blood supply. This shows that the new device's risks are "substantially equivalent" to the predicate device's risks. In order to show the utility of the new device, validate electrical safety, or examine electromagnetic interference, the testing also involves animal and bench studies.

COVID-19 has created an enormous demand for these services. The growth was not significant during the first half, but it became more significant during the second as the industry adopted the new norms at a faster pace amid the pandemic. Numerous projects that were halted because of COVID have been restarted and PPE kits are witnessing an increase in production and testing. During the pandemic, many medical devices in high demand diverted attention from the equipment needed for surgery. The COVID-19 vaccines, ventilators, and pulse oximeters are the main products that witnessed a spike in demand.

Preclinical Medical Device Testing Services Market Report Highlights:

  • In 2024, the biocompatibility tests segment dominated the market, accounting for a revenue share of 45.06%. The test is a critical step for medical device development where an assessment of biocompatibility helps medical device manufacturers ensure the device's safety for patients & provides data that can be used to support regulatory compliance.
  • The chemistry test segment is anticipated to exhibit the fastest CAGR of 9.63%. The test is conducted in order to categorize, recognize, and understand the chemicals used in the production of medical devices
  • Asia Pacific led the global market in 2024 and is projected to witness the fastest CAGR of 9.47% during the forecast years due to the low cost of outsourcing medical device testing services

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis
    • 1.6.2. Bottom-up Approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Preclinical Medical Device Testing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Complexity in product design
      • 3.2.1.2. Strict approval norms
      • 3.2.1.3. Increase in number of small medical device lacking in-house testing capabilities
      • 3.2.1.4. Intense competition in medical device industry
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Legal and Regulatory Issues
  • 3.3. Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Preclinical Medical Device Testing Services Market: Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Preclinical Medical Device Testing Services Market; Method Movement Analysis
  • 4.3. Global Preclinical Medical Device Testing Services Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
  • 4.4. Biocompatibility Tests
    • 4.4.1. Biocompatibility tests market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Chemistry Test
    • 4.5.1. Chemistry test market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Microbiology & Sterility Testing
    • 4.6.1. Microbiology & sterility testing market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Bioburden Determination
      • 4.6.2.1. Bioburden determination market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Pyrogen & Endotoxin Testing
      • 4.6.3.1. Pyrogen & endotoxin testing market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4. Sterility Test and Validation
      • 4.6.4.1. Sterility test and validation market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.6.4.2. Ethylene Oxide (EO) gas sterilization
        • 4.6.4.2.1. Ethylene oxide (EO) gas sterilization market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.6.4.3. Gamma-irradiation
        • 4.6.4.3.1. Gamma-irradiation market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.6.4.4. E-beam sterilization
        • 4.6.4.4.1. E-beam sterilization market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.6.4.5. X-ray sterilization
        • 4.6.4.5.1. X-ray sterilization market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.5. Antimicrobial Activity Testing
      • 4.6.5.1. Antimicrobial activity testing market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.6. Others
      • 4.6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Package Validation
    • 4.7.1. Package validation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Preclinical Medical Device Testing Services Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. North America
    • 5.3.1. North America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Competitive scenario
      • 5.3.2.3. Regulatory framework
      • 5.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Competitive scenario
      • 5.3.3.3. Regulatory framework
      • 5.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key country dynamics
      • 5.3.4.2. Competitive scenario
      • 5.3.4.3. Regulatory framework
      • 5.3.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Competitive scenario
      • 5.4.2.3. Regulatory framework
      • 5.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Competitive scenario
      • 5.4.3.3. Regulatory framework
      • 5.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Competitive scenario
      • 5.4.4.3. Regulatory framework
      • 5.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Competitive scenario
      • 5.4.5.3. Regulatory framework
      • 5.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Competitive scenario
      • 5.4.6.3. Regulatory framework
      • 5.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Denmark
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Competitive scenario
      • 5.4.7.3. Regulatory framework
      • 5.4.7.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.8. Sweden
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Competitive scenario
      • 5.4.8.3. Regulatory framework
      • 5.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.9. Norway
      • 5.4.9.1. Key country dynamics
      • 5.4.9.2. Competitive scenario
      • 5.4.9.3. Regulatory framework
      • 5.4.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Competitive scenario
      • 5.5.2.3. Regulatory framework
      • 5.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. China
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Competitive scenario
      • 5.5.3.3. Regulatory framework
      • 5.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Competitive scenario
      • 5.5.4.3. Regulatory framework
      • 5.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Competitive scenario
      • 5.5.5.3. Regulatory framework
      • 5.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Competitive scenario
      • 5.5.6.3. Regulatory framework
      • 5.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.7. Thailand
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Competitive scenario
      • 5.5.7.3. Regulatory framework
      • 5.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Competitive scenario
      • 5.6.2.3. Regulatory framework
      • 5.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Competitive scenario
      • 5.6.3.3. Regulatory framework
      • 5.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Competitive scenario
      • 5.7.2.3. Regulatory framework
      • 5.7.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Competitive scenario
      • 5.7.3.3. Regulatory framework
      • 5.7.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Competitive scenario
      • 5.7.4.3. Regulatory framework
      • 5.7.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Competitive scenario
      • 5.7.5.3. Regulatory framework
      • 5.7.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Company Market Position Analysis, 2024
  • 6.3. Company Profiles
    • 6.3.1. SGS SA
      • 6.3.1.1. Company overview
      • 6.3.1.2. Financial performance
      • 6.3.1.3. Service benchmarking
      • 6.3.1.4. Strategic initiatives
    • 6.3.2. Eurofins Scientific
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Service benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. Pace Analytical Services LLC
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Service benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. Intertek Group Plc
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Service benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. WUXI APPTEC
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Service benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. TUV SUD AG
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Service benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Sterigenics International LLC
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Service benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Nelson Labs
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Service benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. North American Science Associates, Inc.
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Service benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Charles River Laboratories International, Inc.
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Service benchmarking
      • 6.3.10.4. Strategic initiatives